When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy
about
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaMonoclonal antibodies targeting CD38 in hematological malignancies and beyondSystematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma.Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?An update on the role of daratumumab in the treatment of multiple myeloma.The safety of daratumumab for the treatment of multiple myeloma.Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab.Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.New developments in the treatment of multiple myeloma - clinical utility of daratumumab.Daratumumab for the treatment of multiple myeloma.Practical approaches and costs for provisioning safe transfusions during anti-CD38 therapy.Safety issues and management of toxicities associated with new treatments for multiple myeloma.Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy.International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing.Interference of daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody.Role of daratumumab in transfusion medicine: a must know entity.How do I work up pretransfusion samples containing anti-CD38?Immunotherapy Strategies Against Multiple Myeloma.Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.Daratumumab: Dawn of a New Paradigm in Multiple Myeloma?Transfusion management for patients taking an anti-CD38 monoclonal antibody.Daratumumab for the Treatment of Multiple Myeloma.51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), Lübeck, 19.-21. September 2018, Abstracts
P2860
Q26745919-13D8F91D-EDDB-4AF9-99C1-8167D213A350Q26766718-CE5F3F6F-947F-4D13-8D73-0941F65C815FQ33441476-784B3E80-5531-483A-ACA1-F0527C19D28BQ37076421-60009FF4-00A5-4FB8-B5B4-3CAEAD9F337DQ38623790-8CB205C9-9E7F-4726-B11A-5697F83DDDD7Q38775700-2598FCD0-AD83-4E54-B647-8BCD40D9553FQ38793959-72A644D3-61BC-4D63-ACB3-C6086A93962EQ38809499-AE2D9E2F-12D7-4B5F-ACAC-CE71B92F6C36Q38817467-5A471B95-9654-40A0-92D2-2E74432773AFQ38820002-07EFE9E0-2973-4CD0-9CD7-356D2FA96A6FQ38824538-6630DC95-5828-4FED-9150-E145FD354DC5Q38985014-C69DA64D-7DE5-4E93-AF0A-677C0A324C49Q39100317-77B22A7D-A431-4CDF-A17B-2521C46BFA87Q39177792-DE84CD5E-1C3A-4924-83B1-5007AD2A7CF6Q39417506-6683C514-D804-43EE-BA50-0E6D0AA67307Q42003178-C83CFFD0-C551-4919-9D3B-DA49FBFA5EC3Q45719678-E314E391-4392-49B9-AB1A-A64B4AC72575Q48187335-CAAD8A1A-676C-4854-8E4F-1A0AB7EEFEFCQ49995864-DFE48139-A1A4-40D8-935B-FB1B39452C8CQ50211747-EC171E29-98D8-45FB-87E4-091560BFE85DQ51412052-34883D45-93F5-42EA-BE94-E479442B3583Q55021985-0F87E047-4522-4CBF-8AD8-2217D91E440FQ55261498-F8B35CF4-78D9-42E7-91AF-D0282ED981A0Q55337411-D5C62BD4-25AA-4130-B799-923C7F79C8F6Q58721513-F1EEF67A-BBDF-415C-9DFB-D96226B4BA0C
P2860
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy
description
scientific article published on 18 May 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2015
@uk
name
When blood transfusion medicin ...... by monoclonal antibody therapy
@en
When blood transfusion medicin ...... by monoclonal antibody therapy
@nl
type
label
When blood transfusion medicin ...... by monoclonal antibody therapy
@en
When blood transfusion medicin ...... by monoclonal antibody therapy
@nl
prefLabel
When blood transfusion medicin ...... by monoclonal antibody therapy
@en
When blood transfusion medicin ...... by monoclonal antibody therapy
@nl
P2093
P2860
P356
P1433
P1476
When blood transfusion medicin ...... by monoclonal antibody therapy
@en
P2093
Imran Khan
Jeroen J Lammerts van Bueren
Karen M K De Vooght
Marlies Oostendorp
Parul Doshi
Tahamtan Ahmadi
P2860
P304
P356
10.1111/TRF.13150
P433
P577
2015-05-18T00:00:00Z